FDA Requests More Data From Pozen
Pozen Inc. (POZN) shares stumbled $2.02 to close at $16.09 after the FDA requested more data for its migraine drug.
posted by FC Market News at 9:18 AM
Wednesday, December 13, 2006
Previous Posts
- Progen Reports Positive Test Results
- Circuit City Falls On Best Buy's Results
- Scotts Miracle-Gro To Repurchase Stock
- Epix Partners With GlaxoSmithKline
- Best Buy Disappoints
- Nucor Warns
- Sabre Holdings To Be Acquired
- Hubbell Slashed Forecast
- Acquisition Speculation Lifts Continental
- Taro May Be Acquired
0 Comments:
Post a Comment
<< Home